cholesta-5,8-dien-3 beta-ol has been researched along with simvastatin in 2 studies
| Studies (cholesta-5,8-dien-3 beta-ol) | Trials (cholesta-5,8-dien-3 beta-ol) | Recent Studies (post-2010) (cholesta-5,8-dien-3 beta-ol) | Studies (simvastatin) | Trials (simvastatin) | Recent Studies (post-2010) (simvastatin) |
|---|---|---|---|---|---|
| 36 | 1 | 8 | 8,442 | 1,730 | 3,630 |
| Protein | Taxonomy | cholesta-5,8-dien-3 beta-ol (IC50) | simvastatin (IC50) |
|---|---|---|---|
| photoreceptor-specific nuclear receptor | Homo sapiens (human) | 1.164 | |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | 4.426 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.7843 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 9.5 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0034 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0034 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0111 | |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 0.049 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, J; Janssen-Zijlstra, FS; Jira, PE; Rubio-Gozalbo, E; Sengers, RC; Smeitink, JA; van Heyst, AF; Wevers, RA | 1 |
| Björkhem, I; Lövgren-Sandblom, A; Starck, L | 1 |
2 other study(ies) available for cholesta-5,8-dien-3 beta-ol and simvastatin
| Article | Year |
|---|---|
Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome.
Topics: Cholestadienols; Cholesterol; Dehydrocholesterols; Erythrocyte Membrane; Exchange Transfusion, Whole Blood; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant; Simvastatin; Smith-Lemli-Opitz Syndrome | 2000 |
Simvastatin treatment in the SLO syndrome: a safe approach?
Topics: Adolescent; Alanine Transaminase; Cholestadienols; Dehydrocholesterols; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Photosensitivity Disorders; Simvastatin; Smith-Lemli-Opitz Syndrome; Time Factors; Treatment Outcome | 2002 |